Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PNO1
(partner of Nob1) was known as a RNA-binding protein in humans, and its ortholog
PNO1
was reported to participate ribosome and proteasome biogenesis in yeasts. Yet there have been few studies about its functions in mammalian cells, and so far its role in human cells has never been reported, especially in urinary bladder cancer (UBC).We interrogated the cellular functions and clinical significance of
PNO1
in, and its molecular mechanism through microarrays and bioinformatics analysis. Our findings support that
PNO1
participates in promoting proliferation and colonogenesis, while reducing apoptosis of UBC cells, and is also predicted to be associated with the migration and metastasis of UBC
PNO1
knockdown (KD) attenuated the tumorigenesis ability of UBC in mouse.
PNO1
KD led to the altered expression of 1543 genes that are involved in a number of signalling pathways, biological functions and regulation networks. CD44, PTGS2, cyclin D1, CDK1, IL-8, FRA1, as well as
mTOR
, p70 S6 kinase, p38 and Caspase-3 proteins were all down-regulated in
PNO1
KD cells, suggesting the involvement of
PNO1
in inflammatory responses, cell cycle regulation, chemotaxis, cell growth and proliferation, apoptosis, cell migration and invasiveness. This study will enhance our understanding of the molecular mechanism of UBC and may eventually provide novel targets for individualized cancer therapy.
...
PMID:Importance of PNO1 for growth and survival of urinary bladder carcinoma: Role in core-regulatory circuitry. 3180 Jan 62